Company News
Tuesday, May 2, 2017
BRIEF-Concert Pharmaceuticals initiates CTP-543 phase 2 trial in alopecia areata
* Concert Pharmaceuticals initiates ctp-543 phase 2 trial in
alopecia areata
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment